Karyopharm Therapeutics
KPTI
#8718
Rank
HK$1.32 B
Marketcap
HK$72.28
Share price
-1.60%
Change (1 day)
-1.69%
Change (1 year)

Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2025

Volume in USD (price x number of shares), data since 2025

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$0.01 M-99.85%
2025HK$10.27 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Abbott Laboratories
ABT
HK$19.29 MHK$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$0.10 BHK$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$31.74 MHK$82.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$15.29 MHK$26.28 M๐Ÿ‡บ๐Ÿ‡ธ USA